MindBio Files Patent Applications in 15 World Firsts.

Using Voice and AI to Detect Drug & Alcohol Intoxication

• 15 world first discoveries transform our understanding of physiological reactions to neurologically active substances that when consumed, affect the central nervous system and speech.
• The prediction model using AI  and Voice is a world first and sets a new standard for drug and alcohol detection and testing at scale in regulated environments.

Vancouver, British Columbia –– MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF), (the “Company” or “MindBio”), a biotechnology company commercializing AI-driven voice technology for drug and alcohol intoxication detection, is pleased to announce the Company has filed patent applications for its technology that uses voice and AI to detect intoxication.

The technology developed by MindBio is a game changer for intoxication detection, particularly where drug and alcohol testing is mandated by regulators, such as the mining, aviation and construction industries and in law enforcement where high-volume testing at scale for a variety of drugs and alcohol presents major challenges, is time consuming, physically invasive and expensive. 

In a world first, MindBio has developed an AI model that powers its Edge AI Intoxication Detection Kiosks, using over 50 million data points to predict drug and alcohol intoxication with remarkable reliability and accuracy, just by using the human voice.  The Company’s novel discoveries that have led to its patent application filings, allow it to use its prediction technology to detect a range of substances that effect the central nervous system and human cognition and performance. 

The Company also announced today, that it is on track for the delivery of its hardware and software solution, an Edge AI touchscreen kiosk for commercial testing, specifically for the mining and aviation industries by the end of Q2, 2026.

The Company’s CEO Justin Hanka said, “The digital health diagnostics market represents a significant opportunity for MindBio to leverage its Voice AI diagnostics technology with a first mover commercialization advantage in drug and alcohol intoxication detection”.

For further information, please contact:

Justin Hanka, Chief Executive Officer

+61 433140886

justin@mindbiotherapeutics.com

www.mindbiotherapeutics.com

About MindBio Therapeutics Corp.

MindBio is a biotechnology company that is commercialising AI prediction technologies for drug and alcohol intoxication detection via voice analysis. The AI prediction model uses over 50 million data points to predict alcohol intoxication with remarkable accuracy, just by using the human voice. The Company is developing an enterprise platform including Edge-AI kiosks integrating bespoke hardware and software for the detection of drug and alcohol intoxication using the human voice and AI in a range of enterprise environments including the mining industry, aviation, construction and law enforcement.